Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

High pressure processing combined with selected hurdles: Enhancement in the inactivation of vegetative microorganisms.

Authors:
Peiqing Yang Lei Rao Liang Zhao Xiaomeng Wu Yongtao Wang Xiaojun Liao

Compr Rev Food Sci Food Saf 2021 Mar 16;20(2):1800-1828. Epub 2021 Feb 16.

College of Food Science and Nutritional Engineering, National Engineering Research Center for Fruit and Vegetable Processing, Key Laboratory of Fruit and Vegetable Processing of Ministry of Agriculture and Rural Affairs, Beijing Key Laboratory for Food Non-Thermal Processing, China Agricultural University, Beijing, 100083, China.

High pressure processing (HPP) as a nonthermal processing (NTP) technology can ensure microbial safety to some extent without compromising food quality. However, for vegetative microorganisms, the existence of pressure-resistant subpopulations, the revival of sublethal injury (SLI) state cells, and the resuscitation of viable but nonculturable (VBNC) state cells may constitute potential food safety risks and pose challenges for the further development of HPP application. HPP combined with selected hurdles, such as moderately elevated or low temperature, low pH, natural antimicrobials (bacteriocin, lactate, reuterin, endolysin, lactoferrin, lactoperoxidase system, chitosan, essential oils), or other NTP (CO , UV-TiO photocatalysis, ultrasound, pulsed electric field, ultrafiltration), have been highlighted as feasible alternatives to enhance microbial inactivation (synergistic or additive effect). These combinations can effectively eliminate the pressure-resistant subpopulation, reduce the population of SLI or VBNC state cells and inhibit their revival or resuscitation. This review provides an updated overview of the microbial inactivation by the combination of HPP and selected hurdles and restructures the possible inactivation mechanisms.

Download full-text PDF

Source
http://dx.doi.org/10.1111/1541-4337.12724DOI Listing
March 2021

Publication Analysis

Top Keywords

selected hurdles
12
state cells
12
combined selected
8
vegetative microorganisms
8
microbial inactivation
8
vbnc state
8
high pressure
8
pressure processing
8
endolysin lactoferrin
4
lactoferrin lactoperoxidase
4
lactate reuterin
4
antimicrobials bacteriocin
4
bacteriocin lactate
4
reuterin endolysin
4
chitosan essential
4
ntp uv-tio
4
uv-tio photocatalysis
4
photocatalysis ultrasound
4
oils ntp
4
essential oils
4

Keyword Occurance

Similar Publications

Challenges and complexities of discharge planning from a district nursing perspective.

Authors:
Pedro Lino

Br J Community Nurs 2021 Apr;26(4):184-188

Specialist Practitioner District Nurse, Adult Community Healthcare Team-Wycombe Locality, Buckinghamshire.

Over the past 30 years, the Government has been promoting the transition of care from the acute setting to the community setting. Within the community setting, district nurses are described in the latest reports as endorsers of the care close to home. However, with the surge in hospital discharge, the district nursing workforce is faced with further pressure to cope with the drive to move care into the community. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success.

Authors:
Björn Schwander Mark Nuijten Silvia Evers Mickaël Hiligsmann

Pharmacoeconomics 2021 Apr 10;39(4):433-446. Epub 2021 Mar 10.

Department of Health Services Research, CAPHRI-Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Objectives: This research aims to (1) replicate published health economic models, (2) compare reproduced results with original results, (3) identify facilitators and hurdles to model replicability and determine reproduction success, and (4) suggest model replication reporting standards to enhance model reproducibility, in the context of health economic obesity models.

Methods: Four health economic obesity models simulating an adult UK population were identified, selected for replication, and evaluated using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Reproduction results were compared to original results, focusing on cost-effectiveness outcomes, and the resulting reproduction success was assessed by published criteria. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.

Authors:
Mrinalini Das Taanya Mathur Shilpa Ravi Augusto C Meneguim Aparna Iyer Homa Mansoor Stobdan Kalon Farah Naz Hossain Shrikala Acharya Gabriella Ferlazzo Petros Isaakidis Harshad P Thakur

PLoS One 2021 10;16(3):e0248408. Epub 2021 Mar 10.

Tata Institute of Social Sciences, Mumbai, India.

Background: Childhood multidrug-resistant TB (MDR-TB) still affects around 25000 children every year across the globe. Though the treatment success rates for drug-resistant TB (DR-TB) in children are better than adults, children and adolescents face unique hurdles during DR-TB (MDR-TB, Pre-XDR TB and XDR-TB) treatment. This study aimed to understand the patients, guardians and healthcare providers' perspectives about DR-TB treatment journey of patients and caregivers. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Authors:
Esther Redin Irati Garmendia Teresa Lozano Diego Serrano Yaiza Senent Miriam Redrado Maria Villalba Carlos E De Andrea Francisco Exposito Daniel Ajona Sergio Ortiz-Espinosa Ana Remirez Cristina Bertolo Cristina Sainz Juana Garcia-Pedrero Ruben Pio Juan Lasarte Jackeline Agorreta Luis M Montuenga Alfonso Calvo

J Immunother Cancer 2021 Mar;9(3)

IDISNA and Program in Solid Tumors, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain

Introduction: The use of immune-checkpoint inhibitors has drastically improved the management of patients with non-small cell lung cancer (NSCLC), but innate and acquired resistances are hurdles needed to be solved. Immunomodulatory drugs that can reinvigorate the immune cytotoxic activity, in combination with antiprogrammed cell death 1 (PD-1) antibody, are a great promise to overcome resistance. We evaluated the impact of the SRC family kinases (SFKs) on NSCLC prognosis, and the immunomodulatory effect of the SFK inhibitor dasatinib, in combination with anti-PD-1, in clinically relevant mouse models of NSCLC. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today's Learning Impact Framework Efficiency?

Authors:
Teodora Lalova Anastassia Negrouk Angelique Deleersnijder Peggy Valcke Isabelle Huys

Eur J Health Law 2020 10 21;27(5):425-450. Epub 2020 Oct 21.

Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven Leuven Belgium.

The COVID-19 pandemic has severely disrupted non-coronavirus clinical trials. In the case of life-threatening diseases, such as cancer, this is particularly dangerous, as treatment cannot simply be stopped. In the EU, guidelines for the management of ongoing studies were issued; however, national coordination is still lacking. Read More

View Article and Full-Text PDF
October 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap